SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-052728
Filing Date
2020-11-10
Accepted
2020-11-10 07:05:13
Documents
3
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fulc-8k_20201110.htm 8-K 28231
2 EX-99.1 fulc-ex991_6.htm EX-99.1 174544
3 GRAPHIC gmsuvs4iqtya000001.jpg GRAPHIC 2969
  Complete submission text file 0001564590-20-052728.txt   208117
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38978 | Film No.: 201299596
SIC: 2834 Pharmaceutical Preparations